Results 291 to 300 of about 80,266 (330)

Supplementary Table S4 from CD49d expression identifies a biologically distinct subtype of chronic lymphocytic leukemia with inferior progression-free survival on BTK inhibitor therapy.

Anfal Alsadhan, Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian, Lita A. Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E. Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestner   +16 more
openalex   +1 more source

Exploring pocket-aware inhibitors of BTK kinase by generative deep learning, molecular docking, and molecular dynamics simulations. [PDF]

RSC Adv
Zheng LT, Qian K, Zhang J, Liu MT, Li Y, Yang LQ.   +5 more
europepmc   +1 more source

Development of a Partial Proteolysis Targeting Chimera Library Based on Achiral Cereblon E3 Ligase Ligands and its Application for Bruton's Tyrosine Kinase Degraders. [PDF]

ChemMedChem
Almodóvar-Rivera CM, Tandon I, Mudududdla R, Esguerra PN, Lucio-Acero K, Tang W.   +5 more
europepmc   +1 more source

From C481 Resistance Evasion to Platelet Preservation: Rilzabrutinib Redefines ITP Targeted Therapy. [PDF]

Drug Des Devel Ther
Liu L, Xiao Y, Jia Y, Shao Z, Shi J, Cui C.   +5 more
europepmc   +1 more source

Supplementary Table S1 from PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia

Britten Gordon, Elizabeth M. Muhowski, Jyotsana Singh, Janani Ravikrishnan, Arnau Peris, Daisy Diaz Rohena, John R. Sanchez, Shanmugapriya Thangavadivel, Samon Benrashid, Alexander He, Alexander Marr, Andrew D. Mitchell, Jazmin Urrutia, Shrilekha Misra, Tzung-Huei Lai, Lianbo Yu, Brandi R. Walker, Elizabeth Perry, Guangwu Guo, Nicole R. Grieselhuber, Rogers KA, Rosa Lapalombella, James S. Blachly, Adam S. Kittai, Seema A. Bhat, Nitin Jain, William G. Wierda, John C. Byrd, Michael R. Niesman, Kai Zhang, Deepa Sampath, Jennifer A. Woyach   +31 more
openalex   +1 more source

Genes-first and phenotypes-first paths to treatment resistance in hematological malignancies. [PDF]

Cell Death Dis
Tamellini E, Frusteri C, Ferrarini I.
europepmc   +1 more source

TACI and BTK gene analysis in predominantly antibody deficiencies among the primary immunodeficiency disorder patients in Bangladesh. [PDF]

Front Med (Lausanne)
Chakrobortty T, Roy CK, Islam MI, Niger I, Laila K, Sarker A, Juyee NA, Islam MM, Hoque F, Chakrobortty PP, Ahmed SMA, Sattar ANI.   +11 more
europepmc   +1 more source

Convergerende Communicatiemarkt en -infrastructuur - Openheid Casussen. BTK Programma 2013

, 2013
T.T. Bachet, Frans Berkers, B.M.M. Gijsen, Pieter Nooren   +3 more
openalex   +1 more source